Rapid Applied Research Translation Grant

What is the Rapid Applied Research Translation Grant Opportunity?

The Rapid Applied Research Translation Grant Opportunity is a initiative to support innovative medical research projects that encourage academic researchers and health service providers to collaborate to improve health care delivery, services and systems sustainability.



The 2020 Rapid Applied Research Translation Grant Opportunity was announced as part of the Medical Research Future Fund and the Rapid Applied Research Initiative.  The Australian Government has announced a total of $216 million over ten years from 2019-20 to 2027-28 for the Initiative.

Transformative translational research focuses on turning research findings into real health benefits that help patients, by bringing together several expert groups in health and medical research:

  • universities
  • medical research institutes
  • hospitals
  • primary care networks
  • community based health services
  • consumers and their representative groups.

These groups work together to put new health care solutions into practice across Australia.



The objective of the Rapid Applied Research Translation Grant Opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that:

  • use existing knowledge to develop, test and implement new approaches for the translation of research findings into health care and health interventions that have potential for broader applicability;
  • address a clearly defined gap in the implementation of best practice health care and health interventions to improve health outcomes; and
  • involve all stakeholders relevant to the research and its translation in its conceptualisation, design and implementation, including health care consumers and providers.



For this grant opportunity, $55 million is available over 3 years.

  • $22 million in 2021-22 ($11 million per Stream)
  • $22 million in 2022-23 ($11 million per Stream)
  • $11 million in 2023 -24 ($5.5 million per Stream).

Up to $27.5 million is available for each of the following two streams:

  • Stream 1: Organisations based in urban areas (any area according to the Modified Monash Model Locator )
  • Stream 2: Organisations based in rural areas (MM2 or above according to the Modified Monash Model).

Each will be a separate funding stream. For each stream, applications will be funded based on rank until the total funding available for the stream is reached.

An application may be submitted to one of the above two Streams only.

The grant amount will be up to 100 per cent of eligible project costs (grant percentage). The minimum grant amount is $250,000 and the maximum grant amount is $10 million.


Eligible Projects

To be eligible your project must:

  • be aimed at the objectives
  • have at least $250,000 in eligible expenditure
  • include one or more of the following eligible activities:
    • development/installation of research equipment
    • employment of personnel and/or
    • other direct research costs.


Eligible Applicants

To be eligible you must:

  • have an Australian Business Number (ABN)
  • be incorporated in Australia

and in accordance with s20 and s24 of the MRFF Act 2015, be one of the following entities:

  • a medical research institute
  • a university
  • a corporate Commonwealth entity
  • a corporation (including businesses and not for profits).

Joint applications are encouraged, provided you have a lead organisation who is the main driver of the project and is eligible to apply.

This initiative can only accept applications where you can provide:

  • evidence from your board (or chief executive officer or equivalent if there is no board) that the project is supported, and that you can complete the project and meet the costs of the project not covered by grant funding
  • letters of support from each project partner, where applicable.



Applications close 06 May 2021.


More Information

What is the #1 grant for start-ups?

12,000+ companies access the R&D tax incentive per year that yields a CASH REBATE of up to 43.5%.
This might be perfect your start up.
Do you want to know more?

Scroll to Top
R&D Top 10 Consultant Tips

Top 10 Consultant Tips to Maximise the R&D Tax Incentive